Root Financial Partners’s Zentalis Pharmaceuticals ZNTL Stock Holding History

Root Financial Partners’s Portfolio ZNTL Stock Details ZNTL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$247	Buy	+89	New	+$359	﹤0.01%	3458

Other funds holding ZNTL

Wealth Enhancement Advisory Services Plymouth, Minnesota $67.3B AUM 21.9% 1-Year Est. Return

DLK Investment Management Solana Beach, California $275M AUM 10.69% 1-Year Est. Return

Investment Research & Advisory Group Atlanta, Georgia $337M AUM 19.8% 1-Year Est. Return

Sterling Capital Management Charlotte, North Carolina $4.92B AUM 24.73% 1-Year Est. Return

Nisa Investment Advisors St. Louis, Missouri $34.7B AUM 25.93% 1-Year Est. Return

Fortitude Family Office Scottsdale, Arizona $586M AUM 20.58% 1-Year Est. Return

GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return

SBI Securities Tokyo, Japan $4.38B AUM 56.37% 1-Year Est. Return

Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.86B AUM 20.09% 1-Year Est. Return

Root Financial Partners's ZNTL Position: Q3 2026 in Review

Root Financial Partners opened a new position in Zentalis Pharmaceuticals (ZNTL) in Q3 2026: 89 shares worth $247. The stake represents ﹤0.01% of the portfolio and ranks #3458 among its holdings.

12 funds tracked by Wall St. Rank hold ZNTL as of Q3 2026.

Root Financial Partners held 89 shares of Zentalis Pharmaceuticals worth $247 as of Q3 2026.
Zentalis Pharmaceuticals was a new Root Financial Partners position in Q3 2026.
Zentalis Pharmaceuticals made up ﹤0.01% of Root Financial Partners's portfolio in Q3 2026, its #3458 holding.
12 funds tracked by Wall St. Rank held Zentalis Pharmaceuticals as of Q3 2026.

Based on Root Financial Partners's 13F filing for Q3 2026, filed 21 Oct 2026.